Story detail
Read the key details here, then continue on the original publisher.
Novartis investors are stepping up scrutiny of the company's dealmaking after setbacks to drugs it acquired through mergers and acquisitions
Join our channel to receive the latest headlines and breaking stories as soon as they are published.
A pill from AstraZeneca failed to improve outcomes in closely watched breast cancer study, a result that could limit the use of the medicine.
A late-stage clinical trial found that, when combined with an SMN2-targeting drug, Isembyld caused young patients’ motor skills to improve after a year.
An E.U. AG recommended annulling part of a directive that requires drugmakers to finance 80% of the costs of wastewater treatment.
Nearly 13,000 cases of the illness had been linked to lettuce from Taylor Farms that was processed in Mexico. An investigation into how the parasite spread is continuing.
The largest cyclospora food poisoning outbreak in U.S. history is over, U.S. health officials said, but questions remain over its origin.
Cardiologists are struggling to figure out why a drug that should have prevented heart attacks didn’t work at all.
Comments (0)
Join the conversation. Comments are rate-limited, secured, and GDPR-compliant.
No comments yet. Be the first to share your thoughts!